VIRIDIAN METALS ANNOUNCES INTENTION TO DELIST FROM THE TSXV AND LIST ON THE CSE
Viridian Metals Inc. (TSXV: VRDN) ("Viridian or the "Company") is pleased to announce that it has received the approval of ...
Hosted on MSN1mon
Viridian Therapeutics Stock Hits 3-Week High, Retail Buzz Builds On Chronic Thyroid Eye Disease Trial Data
On Stocktwits, sentiment for Viridian’s stock turned ‘extremely bullish’, with the ticker entering the platform’s top 15 trending symbols. One user described the news as making the stock a ...
Seeking Alpha9mon
VRDN Viridian Therapeutics, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Business Insider1mon
Positive Outlook for Viridian Therapeutics: Analyst Reaffirms Buy Rating on Strong Competitive Position and Efficacy of VRDN-001
In a report released today, Serge Belanger from Needham maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report), with a price target of $38.00. Discover outperforming stocks ...
Business Insider29d
Viridian Therapeutics: Promising Market Position with Superior Efficacy and Safety of Veligrotug in TED Treatment
Analyst Rami Katkhuda from LifeSci Capital maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) and keeping the price target at $46.00. Discover outperforming stocks and ...
Best Junior Mining Stocks5d
Canadian Securities Exchange Welcomes Listing of Viridian Metals
Toronto, Ontario-- (Newsfile Corp. - February 6, 2025) - The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Viridian Metals Inc. ("Viridian" or the "Company").